Seminars in Nuclear Medicine
Volume 38, Issue 2 , Pages 129-136 , March 2008

Technical Aspects of Positron Emission Tomography/Computed Tomography Fusion Planning

  • Jacqueline Brunetti, MD

      Affiliations

    • Department of Radiology, Holy Name Hospital, Teaneck, NJ.
    • Corresponding Author InformationAddress reprint requests to Jacqueline Brunetti, MD, Department of Radiology, Holy Name Hospital, 718 Teaneck Road, Teaneck, NJ 07666.
    • ,
  • Allan Caggiano, MS

      Affiliations

    • Department of Radiation Oncology, Holy Name Hospital, Teaneck, NJ.
    • ,
  • Benjamin Rosenbluth, MD

      Affiliations

    • Department of Radiation Oncology, Holy Name Hospital, Teaneck, NJ.
    • ,
  • Charles Vialotti, MD

      Affiliations

    • Department of Radiation Oncology, Holy Name Hospital, Teaneck, NJ.

References 

  1. Nestle U, Walter K, Schmidt S, et al. 18F-deoxyglucose positron emission tomography (FDG-PET) for planning in radiotherapy in lung cancer: High impact in patients with atelectasis. Int J Radiat Biol Phys. 1999;44:593–597
  2. Vanuytsel LJ, Vansteenkiste JF, Stroobants SG, et al. The impact of 18F-fluoro-2 deoxy-D-glucose positron emission tomography (FDG-PET) lymph staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol. 2000;55:317–324
  3. Erdi Y, Rosenzweig K, Erdi AK, et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol. 2002;62:51–60
  4. Bradley J, Thorstad WL, Mutic A, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small cell lung cancer. Int J Radiat Biol Phys. 2004;59:78–86
  5. van Der Wel A, Nijsten S, Hochstenbag M, et al. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2–N3M0 non-small-cell lung cancer: A modeling study. Int J Radiat Oncol Biol Phys. 2005;61:649–655
  6. Schwartz DL, Ford EC, Rajendran J, et al. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: A pilot investigation. Head Neck. 2005;27:478–487
  7. Wang D, Schultz CJ, Jusinic PA, et al. Initial experience of FDG-PET/CT guided IMRT of head and neck cancer. Int J Radiat Oncol Biol Phys. 2006;65:143–151
  8. Lin LL, Mutic S, Low DA, et al. Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET. Int J Radiat Oncol Biol Phys. 2007;67:91–96
  9. Leong T, Everitt C, Yuen K, et al. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol. 2006;78:254–261
  10. Ciernik IF, Huser M, Burger C, et al. Automated functional image-guided radiation treatment planning for rectal cancer. Int J Radiat Oncol Biol Phys. 2005;62:893–900
  11. Moureau-Zabotto L, Touboul E, Lerouge D, et al. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2005;63:340–345
  12. Weiss E, Hess CF. The impact of gross tumor volume (GTV) and clinical target volume (CTV) definition on the total accuracy in radiotherapy theoretical aspects and practical experiences. Strahlenther Onkol. 2003;179:21–30
  13. Caldwell CB, Mah K, Ung YC, et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: The impact of 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys. 2001;51:923–931
  14. Steenbakkers RJ, Duppen JC, Fitton I, et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: A three-dimensional analysis. Int J Radiat Oncol Biol Phys. 2006;64:435–448
  15. Fox JL, Rengan R, O’Meara W, et al. Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer?. Int J Radiat Oncol Biol Phys. 2005;62:70–75
  16. Van Kampen M, Levegrun S, Wannenmacher M. Target definition in radiation therapy. Br J Radiol. 1997;70(suppl):25–31
  17. Vanden Berge DL, Ridder MD, Storme GA. Imaging in radiotherapy. Eur J Radiol. 2000;36:41–48
  18. van Baardwijk A, Baumert BG, Bosmans G, et al. The current status of FDG-PET in tumor volume definition in radiotherapy treatment planning. Cancer Treat Rev. 2006;32:245–260
  19. Ling CC, Humm J, Larson S, et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Biol Oncol Phys. 2000;47:551–560
  20. Bucci KM, Bevna A, Roach M. Advances in radiation therapy: Conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J Clin. 2005;55:117–134
  21. Zanzonico P. PET-based biological imaging for radiation therapy treatment planning. Crit Rev Eukaryot Gen Expr. 2006;16:61–101
  22. Bertoldo A, Peltoniemi P, Oikonen V, et al. Kinetic modeling of [18F]FDG in skeletal muscle by PET: A four-compartment five-rate-constant model. Am J Physiol Endocrinol Metab. 2001;281:E524–E536
  23. Wolthaus JW, van Herk M, Muller SH, et al. Fusion of respiration-correlated PET and CT scans: Correlated lung tumour motion in anatomical and functional scans. Phys Med Biol. 2005;50:1569–1583
  24. Caggiano A, Vialotti C, Brunetti J: 4D PET/CT: Early observations and impact in radiation therapy planning for lung cancer. Int J Radiat Oncol Biol Phys 60:290 (abstr)
  25. Wurm RE, Gum F, Erbel S, et al. Image guided respiratory gated hypofractionated stereotactic body radiation therapy (H-SBRT) for liver and lung tumors: Initial experience. Acta Oncol. 2006;45:881–889
  26. Giraud P, Yorke E, Ford EC, et al. Reduction of organ motion in lung tumors with respiratory gating. Lung Cancer. 2006;51:41–51
  27. Underberg RW, van Sornsen de Koste JR, Lagerwaard FJ, et al. A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancer. Radiat Oncol. 2006;1:8
  28. Butler LE, Forster KM, Stevens CW, et al. Dosimetric benefits of respiratory gating: A preliminary study. J Appl Clim Med Phys. 2004;5:16–24
  29. Keall PJ, Mageras GS, Balter JM, et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 6. Med Phys. 2006;33:3974-3900
  30. Lorchel F, Dumas JL, Noal A, et al. Dosimetric consequences of breath-hold respiration in conformal radiotherapy of esophageal cancer. Phys Med. 2006;22:119–126
  31. Davis JB, Reiner B, Huser M, et al. Assessment of 18F PET signals for automated target volume definition in radiotherapy treatment planning. Radiother Oncol. 2006;80:43–50
  32. Ford EC, Kinahan PE, Hanlon L, et al. Tumor delineation using PET in head and neck cancers: Threshold contouring and lesion volumes. Med Phys. 2006;33:4280–4288
  33. Nestle U, Kremp S, Schaefer-Schuler A, et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. J Nucl Med. 2005;46:1342–1348
  34. Daisne JF, Duprez T, Weynand B, et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: a comparison at CT, MR imaging and FDG PET and validation with surgical specimen. Radiology. 2004;233:93–100

PII: S0001-2998(07)00139-0

doi: 10.1053/j.semnuclmed.2007.11.001

Seminars in Nuclear Medicine
Volume 38, Issue 2 , Pages 129-136 , March 2008

Article Tools

* Image Usage & Resolution